Compounds > angiotensin ii, des-phe(8)-
Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and Ventricular Dysfunction, Left

angiotensin ii, des-phe(8)- has been researched along with Ventricular Dysfunction, Left in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's7 (63.64)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Chai, CY; Chen, IC; Dai, ZK; Hsu, JH; Lin, JY; Liu, YC; Wu, BN; Yeh, JL1
An, X; Fu, M; He, X; Li, C; Niu, L; Tian, J; Wang, Q; Xu, H1
Guo, L; Han, S; He, W; Li, H; Shen, D; Wang, J; Zhang, Y1
Chen, YG; Gao, F; Hao, PP; Liu, YP; Yang, JM; Zhang, C; Zhang, MX; Zhang, Y1
Chapleau, MW; Sabharwal, R1
Abo Alrob, O; Altamimi, T; Basu, R; Desaulniers, J; Kassiri, Z; Lopaschuk, GD; Mori, J; Oudit, GY; Patel, VB; Wagg, CS1
Chen, Y; Gao, F; Hao, P; Liu, Y; Yang, J; Zhang, C; Zhang, K; Zhang, M; Zhang, Y1
Chen, J; He, Q; Li, Y; Pen, W; Shou, Z; Wu, J; Zhang, P; Zhu, Y1
Ahmad, S; Brosnihan, KB; Chappell, MC; Ferrario, CM; Gallagher, PE; Groban, L; Tallant, EA; Varagic, J1
Dai, GY; Fu, HX; Gao, CY; Li, MW; Liu, HZ; Liu, YH; Niu, ZM; Qi, DT; Wang, XP; Wang, XQ; Yang, HH; Zhang, Y1
Al-Maghrebi, M; Benter, IF; Cojocel, C; Diz, DI; Yousif, MH1

Reviews

1 review(s) available for angiotensin ii, des-phe(8)- and Ventricular Dysfunction, Left

ArticleYear
Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system.
    Experimental physiology, 2014, Volume: 99, Issue:4

    Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Autonomic Nervous System; Cardiomyopathies; Disease Models, Animal; Genotype; Heart; Humans; Mice, Knockout; Motor Activity; Muscle, Skeletal; Muscular Dystrophies, Limb-Girdle; Myocardium; Peptide Fragments; Phenotype; Renin-Angiotensin System; Sarcoglycans; Ventricular Dysfunction, Left; Ventricular Function, Left

2014

Other Studies

10 other study(ies) available for angiotensin ii, des-phe(8)- and Ventricular Dysfunction, Left

ArticleYear
The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.
    International journal of medical sciences, 2020, Volume: 17, Issue:16

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Activators; Humans; Hypertension, Pulmonary; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Ventricular Dysfunction, Left

2020
Angiotensin-(1-7) protects against sepsis-associated left ventricular dysfunction induced by lipopolysaccharide.
    Peptides, 2021, Volume: 144

    Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Cardiotonic Agents; Cells, Cultured; Inflammation; Lipopolysaccharides; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Nerve Tissue Proteins; Peptide Fragments; Proto-Oncogene Mas; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Sepsis; Ventricular Dysfunction, Left

2021
The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.
    Molecular medicine reports, 2017, Volume: 16, Issue:2

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Collagen; Fibrosis; Heart Function Tests; Immunohistochemistry; Male; Myocardial Infarction; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Remodeling

2017
Association of plasma angiotensin-(1-7) level and left ventricular function in patients with type 2 diabetes mellitus.
    PloS one, 2013, Volume: 8, Issue:5

    Topics: Aged; Angiotensin I; Diabetes Mellitus, Type 2; Female; Humans; Male; Peptide Fragments; Stroke Volume; Ventricular Dysfunction, Left

2013
Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
    Circulation. Heart failure, 2014, Mar-01, Volume: 7, Issue:2

    Topics: Angiotensin I; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diastole; Echocardiography, Doppler; Follow-Up Studies; Inflammation; Insulin Resistance; Lipids; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function; Ventricular Pressure

2014
Combination of angiotensin-(1-7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy.
    Scientific reports, 2015, Mar-05, Volume: 5

    Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Blood Glucose; Cardiomegaly; Cell Communication; Cell Differentiation; Cell Proliferation; Collagen; Diabetic Cardiomyopathies; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Fibroblasts; Fibrosis; Heart Ventricles; Hemodynamics; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Perindopril; Phosphorylation; Rats; Receptors, Angiotensin; Transforming Growth Factor beta1; Ventricular Dysfunction, Left

2015
Angiotensin (1-7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2009, Volume: 32, Issue:5

    Topics: Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Creatinine; Heart Failure; Heart Ventricles; Kidney; Kidney Failure, Chronic; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Transforming Growth Factor beta; Ventricular Dysfunction, Left; Ventricular Remodeling

2009
Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction.
    Therapeutic advances in cardiovascular disease, 2010, Volume: 4, Issue:1

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Receptors, G-Protein-Coupled; Renin; RNA, Messenger; Sodium Chloride, Dietary; Ventricular Dysfunction, Left; Ventricular Remodeling

2010
[Angiotensin(1-7) attenuates left ventricular dysfunction and myocardial apoptosis on rat model of adriamycin-induced dilated cardiomyopathy].
    Zhonghua xin xue guan bing za zhi, 2012, Volume: 40, Issue:3

    Topics: Angiotensin I; Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Cardiomyopathy, Dilated; Caspase 3; Doxorubicin; Heart; Male; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Wistar; Ventricular Dysfunction, Left

2012
Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:1

    Topics: Angiotensin I; Animals; Blood Pressure; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Male; Peptide Fragments; Rats; Rats, Wistar; Streptozocin; Vasoconstriction; Vasodilation; Ventricular Dysfunction, Left

2007